Pima County's 2015 Community Health Needs Assessment (CHNA) identified the following four areas as health priorities for Pima County:
Diabetes was identified as the 8th leading cause of death in Pima County. To address the rising prevalence of diabetes in Pima County, Healthy Pima's Together 2 End Diabetes coalition is currently working to provide more education, advocacy, resources, and self-management support to community members with diabetes and pre-diabetes.
Arizona's injury rate is higher than the national average with a primary focus on motor vehicle crashes as the leading cause of accidental injury and death in Pima County. Collaborative efforts among three Healthy Pima coalitions are currently underway to prevent and reduce the morbidity and mortality associated with injuries and accidents among youth, adults, and seniors.
Community members voiced a need for more mental health and substance misuse interventions in Pima County, especially around anxiety, depression and opioid misuse. Due to the county’s upward trend in co-morbidity of mental and substance misuse disorders, Healthy Pima has pulled together an interdisciplinary alliance of six task forces to increase community awareness, decrease substance dependence, and increase access to mental and behavioral health services for members of Pima County.
The final version of the Arizona Opioid Prescribing Guidelines - a voluntary, consensus set of guidelines that promote best practices for prescribing opioids for acute and chronic pain - have been released.
The goal of these guidelines is to balance the appropriate treatment of pain with approaches to more safely prescribe opioids. The guidelines are intended for use by a variety of clinicians in primary care and specialty outpatient settings who treat acute pain and/or manage chronic pain that is not occurring at the end of life and not due to malignancy.
The Arizona Opioid Prescribing Guidelines complement other statewide documents articulating best practices for Emergency Department Controlled Substance Prescribing and Dispensing Controlled Substances. Additionally, Healthy Pima's Medical Practices Task Force Action Plan also aligns with these recommendations.
Join Julie Seidl for a discussion surrounding a newborn's behaviors when exposed to drug use, neonatal abstinence syndrome, and how newborns are affected at birth by exposure to opiates.
Date: Friday, June 1, 2018
Time: 9:00 AM - 12:00 PM
Location: Pima County Health Department (first floor conference rooms), 3950 South Country Club Road
Recently, Arizona law enforcement in the metropolitan Phoenix area made their first confirmed drug seizure of counterfeit pills containing CARFENTANIL (also spelled CARFENTANYL). Several hundred pills packaged for sale were seized. The pills were light blue in color and imprinted with an “A 215” marking (see photo on page 2). Previous counterfeit pill seizures with the “A 215” marking have contained FENTANYL or its analogues. These pills are sold on the streets as “blues”, “Oxy”, “Oxys” and are made to appear as pharmaceutically produced 30 mg oxycodone pills.
Carfentanil is an extremely powerful, deadly synthetically produced opioid analgesic compound. It is 10,000 times more powerful than morphine, 1,000 times more powerful than heroin, and 100 times more powerful than fentanyl. A 20 micro-gram dosage (size equivalency to 1/3rd of a single grain of salt) is lethal to humans. There are no medically approved uses for this drug in humans. Its only legitimate use is to sedate elephants.
CNA would like to inform people that should they come in contact with a substance they believe may contain carfentanil, not to handle the substance. Leave it in place, evacuate people from the immediate area of an exposure, close off the area from ventilation sources that may spread the substance, and dial 911. Advise 911 of your situation and wait for help.